Balchem Corporation (BCPC) FY2026 Q2 P&L / Income Statement

Revenue by Business Segment

2026-04-01 to 2026-06-30

Swipe to see the full flow
Balchem Corporation (BCPC) FY2026 Q2 P&L / Income StatementIncome statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUE RECONCILIATIONREVENUEGROSSOPERATINGPRE-TAXNETHuman Nutrition And HealthAnimal Nutrition And HealthSpecialty ProductsNet salesRevenue before reconciliation (calculated)Other and UnallocatedGross marginCost of salesEarnings from operationsTotal operating expensesSelling expensesGeneral and administrative expensesResearch and development expensesEarnings before income tax expenseTotal other (income) expensesNet earningsIncome tax expenseRevenue before reconciliation (calculated)Revenue beforereconciliation(calculated)$281.86 MEarnings from operationsEarnings fromoperations$59.22 MEarnings before income tax expenseEarnings beforeincome tax expense$57.78 MNet salesNet sales$284.00 MGross marginGross margin$103.68 MNet earningsNet earnings$44.62 MHuman Nutrition And HealthHNH$176.89 MTotal operating expensesTotal operatingexpenses$44.46 MIncome tax expenseIncome tax expense$13.17 MSelling expensesSelling expenses$21.14 MCost of salesCost of sales$180.31 MTotal other (income) expensesTotal other(income) expenses−$1.44 MGeneral and administrative expensesGeneral andadministrative expenses$18.79 MAnimal Nutrition And HealthANH$64.45 MResearch and development expensesResearch anddevelopment expenses$4.53 MSpecialty ProductsSP$40.51 MOther and UnallocatedOther and Unallocated$2.14 M
Chart details

Balchem Corporation (BCPC) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales
283,997,000 US dollars
Cost of sales
180,314,000 US dollars
Gross margin
103,683,000 US dollars
Total operating expenses
44,462,000 US dollars
Earnings from operations
59,221,000 US dollars
Total other (income) expenses
negative 1,440,000 US dollars
Earnings before income tax expense
57,781,000 US dollars
Income tax expense
13,166,000 US dollars
Net earnings
44,615,000 US dollars
Human Nutrition And Health
176,894,000 US dollars
Animal Nutrition And Health
64,454,000 US dollars
Specialty Products
40,511,000 US dollars
Selling expenses
21,137,000 US dollars
Research and development expenses
4,534,000 US dollars
General and administrative expenses
18,791,000 US dollars
Revenue before reconciliation (calculated)
281,859,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
Other and Unallocated
2,138,000 US dollars. Reported reconciliation to consolidated revenue.
Human Nutrition And Health costs (calculated)
134,513,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Animal Nutrition And Health costs (calculated)
59,227,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Specialty Products costs (calculated)
27,618,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Reconciling items (calculated)
3,418,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
Balchem Corporation (BCPC) FY2026 Q2 Revenue by Business Segment Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

36.5%

Gross profit / revenue

Operating margin

20.9%

Operating profit / revenue

Cash conversion

104.7%

Operating cash / net income, same period

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!